New Zealand markets closed

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
326.54-13.03 (-3.84%)
At close: 4:00PM EDT
326.00 -0.54 (-0.17%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5130.87B
Enterprise value 3123.48B
Trailing P/E 40.53
Forward P/E 111.16
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)19.07
Price/book (mrq)19.52
Enterprise value/revenue 317.59
Enterprise value/EBITDA 731.39

Trading information

Stock price history

Beta (5Y monthly) 1.49
52-week change 3364.89%
S&P500 52-week change 333.64%
52-week high 3497.49
52-week low 365.49
50-day moving average 3378.59
200-day moving average 3282.11

Share statistics

Avg vol (3-month) 316.55M
Avg vol (10-day) 39.81M
Shares outstanding 5403.65M
Implied shares outstanding 6N/A
Float 8344.7M
% held by insiders 19.65%
% held by institutions 157.07%
Shares short (29 Sep 2021) 414.33M
Short ratio (29 Sep 2021) 41.06
Short % of float (29 Sep 2021) 44.85%
Short % of shares outstanding (29 Sep 2021) 43.55%
Shares short (prior month 30 Aug 2021) 413.77M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin 49.79%
Operating margin (ttm)54.39%

Management effectiveness

Return on assets (ttm)24.30%
Return on equity (ttm)72.43%

Income statement

Revenue (ttm)7.02B
Revenue per share (ttm)17.62
Quarterly revenue growth (yoy)6,398.50%
Gross profit (ttm)-574.88M
Net income avi to common (ttm)3.49B
Diluted EPS (ttm)8.46
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.99B
Total cash per share (mrq)19.8
Total debt (mrq)603M
Total debt/equity (mrq)8.99
Current ratio (mrq)1.24
Book value per share (mrq)16.64

Cash flow statement

Operating cash flow (ttm)9.19B
Levered free cash flow (ttm)8.16B